Monographs for use of immunosuppressants in Immune-related adverse events (irAEs)
The Immune-Related Adverse Effects that arise from use of checkpoint inhibitors can be difficult to manage, especially when steroids are not enough. Despite there being guidance about how to manage these patients, information on the practical use of second-line agents is lacking.
Over the past year the Immunotherapy Specialist Interest Group has been working on producing high quality information to support the use of subsequent line immunosupressants for patients with irAEs in whom steroids are not enough. The first four of these monographs are now available for the membership to access on the resources section of the Immunotherapy page on the BOPA website.
The monographs are also available via the useful website pages or directly from this link.
More to follow later in the year.